Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung Cancer.
Journal: bioRxiv : the preprint server for biology
Published: September 19, 2025
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer.
Journal: Molecular cancer therapeutics
Published: September 18, 2025
Germline BAP1 Mutation-Associated Mesothelioma: A Biologically and Clinically Distinct Entity.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 29, 2025
Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 19, 2025
Mapping drug distribution using CT imaging following direct tissue injection in ex vivo liver: informing clinical implementation.
Journal: CVIR oncology
Published: May 13, 2025
Local Ablative Therapy Followed by Osimertinib Rechallenge in Oligoprogressive, EGFR-Mutated NSCLC: A Phase 2 Study.
Journal: JTO clinical and research reports
Published: February 26, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2025
Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome.
Journal: JAMA dermatology
Published: May 17, 2024
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.
Journal: Nature medicine
Published: January 03, 2023
Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 18, 2022
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene.
Journal: JTO clinical and research reports
Published: July 19, 2021
Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 29, 2021
Last Updated: 09/26/2026